These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

377 related articles for article (PubMed ID: 34068120)

  • 21. Triterpenoid Saponin AG8 from
    Mu LH; Wang LH; Yu TF; Wang YN; Yan H; Liu P; Yan C
    Oxid Med Cell Longev; 2020; 2020():7963212. PubMed ID: 33123316
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Twist1 expression induced by sunitinib accelerates tumor cell vasculogenic mimicry by increasing the population of CD133+ cells in triple-negative breast cancer.
    Zhang D; Sun B; Zhao X; Ma Y; Ji R; Gu Q; Dong X; Li J; Liu F; Jia X; Leng X; Zhang C; Sun R; Chi J
    Mol Cancer; 2014 Sep; 13():207. PubMed ID: 25200065
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Niclosamide sensitizes triple-negative breast cancer cells to ionizing radiation in association with the inhibition of Wnt/β-catenin signaling.
    Yin L; Gao Y; Zhang X; Wang J; Ding D; Zhang Y; Zhang J; Chen H
    Oncotarget; 2016 Jul; 7(27):42126-42138. PubMed ID: 27363012
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Metabolic heterogeneity in TNBCs: A potential determinant of therapeutic efficacy of 2-deoxyglucose and metformin combinatory therapy.
    Samuel SM; Varghese E; Satheesh NJ; Triggle CR; Büsselberg D
    Biomed Pharmacother; 2023 Aug; 164():114911. PubMed ID: 37224753
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lipid nanocarriers of a lipid-conjugated estrogenic derivative inhibit tumor growth and enhance cisplatin activity against triple-negative breast cancer: pharmacokinetic and efficacy evaluation.
    Andey T; Sudhakar G; Marepally S; Patel A; Banerjee R; Singh M
    Mol Pharm; 2015 Apr; 12(4):1105-20. PubMed ID: 25661724
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genomic insights into triple-negative and HER2-positive breast cancers using isogenic model systems.
    Mudvari P; Ohshiro K; Nair V; Horvath A; Kumar R
    PLoS One; 2013; 8(9):e74993. PubMed ID: 24086418
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Functional interactions between the LRP6 WNT co-receptor and folate supplementation.
    Gray JD; Nakouzi G; Slowinska-Castaldo B; Dazard JE; Rao JS; Nadeau JH; Ross ME
    Hum Mol Genet; 2010 Dec; 19(23):4560-72. PubMed ID: 20843827
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tailored-CuO-nanowire decorated with folic acid mediated coupling of the mitochondrial-ROS generation and miR425-PTEN axis in furnishing potent anti-cancer activity in human triple negative breast carcinoma cells.
    Ahir M; Bhattacharya S; Karmakar S; Mukhopadhyay A; Mukherjee S; Ghosh S; Chattopadhyay S; Patra P; Adhikary A
    Biomaterials; 2016 Jan; 76():115-32. PubMed ID: 26520043
    [TBL] [Abstract][Full Text] [Related]  

  • 29.
    Liu H; Sun H; Zhang B; Liu S; Deng S; Weng Z; Zuo B; Yang J; He Y
    Breast Cancer; 2020 May; 27(3):372-380. PubMed ID: 31781983
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dual Src Kinase/Pretubulin Inhibitor KX-01, Sensitizes ERα-negative Breast Cancers to Tamoxifen through ERα Reexpression.
    Anbalagan M; Sheng M; Fleischer B; Zhang Y; Gao Y; Hoang V; Matossian M; Burks HE; Burow ME; Collins-Burow BM; Hangauer D; Rowan BG
    Mol Cancer Res; 2017 Nov; 15(11):1491-1502. PubMed ID: 28751463
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterization of HJ-PI01 as a novel Pim-2 inhibitor that induces apoptosis and autophagic cell death in triple-negative human breast cancer.
    Zhao YQ; Yin YQ; Liu J; Wang GH; Huang J; Zhu LJ; Wang JH
    Acta Pharmacol Sin; 2016 Sep; 37(9):1237-50. PubMed ID: 27397540
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Combination of sirtuin 3 and hyperoxia diminishes tumorigenic properties of MDA-MB-231 cells.
    Podgorski II; Pinterić M; Marčinko D; Popović Hadžija M; Filić V; Ciganek I; Pleše D; Balog T; Sobočanec S
    Life Sci; 2020 Aug; 254():117812. PubMed ID: 32428596
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mitochondrial dysfunction in some triple-negative breast cancer cell lines: role of mTOR pathway and therapeutic potential.
    Pelicano H; Zhang W; Liu J; Hammoudi N; Dai J; Xu RH; Pusztai L; Huang P
    Breast Cancer Res; 2014 Sep; 16(5):434. PubMed ID: 25209360
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Myoferlin regulates cellular lipid metabolism and promotes metastases in triple-negative breast cancer.
    Blomme A; Costanza B; de Tullio P; Thiry M; Van Simaeys G; Boutry S; Doumont G; Di Valentin E; Hirano T; Yokobori T; Gofflot S; Peulen O; Bellahcène A; Sherer F; Le Goff C; Cavalier E; Mouithys-Mickalad A; Jouret F; Cusumano PG; Lifrange E; Muller RN; Goldman S; Delvenne P; De Pauw E; Nishiyama M; Castronovo V; Turtoi A
    Oncogene; 2017 Apr; 36(15):2116-2130. PubMed ID: 27775075
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Integrated Metabolomics and Transcriptomics Analysis of Anacardic Acid Inhibition of Breast Cancer Cell Viability.
    Piell KM; Poulton CC; Stanley CG; Schultz DJ; Klinge CM
    Int J Mol Sci; 2024 Jun; 25(13):. PubMed ID: 39000156
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Different mechanisms involved in the berberine-induced antiproliferation effects in triple-negative breast cancer cell lines.
    Lin YS; Chiu YC; Tsai YH; Tsai YF; Wang JY; Tseng LM; Chiu JH
    J Cell Biochem; 2019 Aug; 120(8):13531-13544. PubMed ID: 30957305
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Loss of Fer Jeopardizes Metabolic Plasticity and Mitochondrial Homeostasis in Lung and Breast Carcinoma Cells.
    Mehazri L; Shpungin S; Bel S; Nir U
    Int J Mol Sci; 2021 Mar; 22(7):. PubMed ID: 33806191
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A Novel Cytotoxic Mechanism for Triple-Negative Breast Cancer Cells Induced by the Type II Heat-Labile Enterotoxin LT-IIc through Ganglioside Ligation.
    King-Lyons ND; Bhati AS; Hu JC; Mandell LM; Shenoy GN; Willison HJ; Connell TD
    Toxins (Basel); 2024 Jul; 16(7):. PubMed ID: 39057951
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mitochondrial adaptation decreases drug sensitivity of persistent triple negative breast cancer cells surviving combinatory and sequential chemotherapy.
    Winter M; Nait Eldjoudi A; Guette C; Hondermarck H; Bourette RP; Fovez Q; Laine W; Ghesquiere B; Adriaenssens E; Kluza J; Le Bourhis X
    Neoplasia; 2023 Dec; 46():100949. PubMed ID: 37956532
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Research resource: global identification of estrogen receptor β target genes in triple negative breast cancer cells.
    Shanle EK; Zhao Z; Hawse J; Wisinski K; Keles S; Yuan M; Xu W
    Mol Endocrinol; 2013 Oct; 27(10):1762-75. PubMed ID: 23979844
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.